Literature DB >> 14259993

THE NATURE OF MYCOBACTERIAL PENICILLINASE.

J E KASIK.   

Abstract

Keywords:  CHEMISTRY; METHICILLIN; MYCOBACTERIUM TUBERCULOSIS; PENICILLIN G; PENICILLINASE

Mesh：

Substances：

Year:  1965        PMID： 14259993     DOI： 10.1164/arrd.1965.91.1.117

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN： 0003-0805


× No keyword cloud information.
  15 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 2.  Current development and future prospects in chemotherapy of tuberculosis.

Authors:  Eric L Nuermberger; Melvin K Spigelman; Wing Wai Yew
Journal:  Respirology       Date:  2010-06-04       Impact factor: 6.424

3.  Immunological distinction of mycobacterial beta-lactamases.

Authors:  J S Thompson; C D Severson; N A Stearns; J E Kasik
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

4.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

5.  Properties of beta-lactamases produced by three species of mycobacteria.

Authors:  J E Kasik; L Peacham
Journal:  Biochem J       Date:  1968-05       Impact factor: 3.857

6.  Imipenem for treatment of tuberculosis in mice and humans.

Authors:  Henry F Chambers; Joan Turner; Gisela F Schecter; Masae Kawamura; Philip C Hopewell
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

8.  Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

Authors:  R K Voladri; D L Lakey; S H Hennigan; B E Menzies; K M Edwards; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

Review 9.  Reappraising the use of β-lactams to treat tuberculosis.

Authors:  Sebastian G Kurz; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

10.  Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

Authors:  H F Chambers; D Moreau; D Yajko; C Miick; C Wagner; C Hackbarth; S Kocagöz; E Rosenberg; W K Hadley; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.